A recent review paper published in the journal MDPI provides evidence-based recommendations on using intravitreal dexamethasone implants (DEX) for treating DME.
Ochsner Health is the leading nonprofit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers.